课题基金 / 基金详情

Regulatory mechanisms underlying IL-12 production and the control of immune responses

Regulatory mechanisms underlying IL-12 production and the control of immune responses
IL-12 产生和免疫反应控制的调控机制
批准号:
08839013
负责人:
ONO Shiro
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

ONO Shiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
IL-12 secreted by macrophages (Mphi) is a critical cytokine for the induction of Th1 cells responsible for cellular immunity. Here we investigated mechanisms underlying the regulation of IL-12 production. 1. The non-MHC linked strain difference in the T-cell independent IL-12 production by murine splenic Mphi to LPS plus IFN-gamma stimulation was closely related with simultaneous production of IL-10 capable of inhibiting IL-12 synthesis. 2. In contrast to splenic Mphi, peritoneal Mphi failed to induce IL-12 upon stimulation with LPS + IFN-gamma or SAC + IFN-gamma due to high production of IL-10 and PGE2.3. Peritoneal Mphi from mice given complete Freund's adjuvant (CFA) acquired the ability to produce IL-12 to the stimulation. Interestingly, levels of IL-10 and PGE2 were markedly reduced in such CFA-treated peritoneal Mphi. 4. Analyzes of cell surface antigens by flow cytometry revealed that the expression of STK (stem cell-derived tyrosine kinase, a member of the hepatocyte growth factor receptor family) on normal peritoneal Mphi was remarkably decreased after CFA-treatment. This implies the association of IL-12-producing ability with downregulation of STK as well as IL-10 and PGE2.5. High IL-12 production was induced even by untreated peritoneal Mphi from SJL/J mice exhibing a high incidence of experimental autoimmune encephalomyelitis mediated by Th1 cells and from MRL/Ipr mice spontaneously developing systemic autoimmune disease. 6. The presence of B cells constitutively expressing CD40 dramatically inhibited the T-cell dependent IL-12 induction to Con A or anti-CD3epsilon mAb stimulation, in which T-Mphi cell interaction through CD40L-CD40 molecules was required. This inhibition seemed to be caused by a competitive blocking of T-Mphi cell interaction by B cells incapable of producing IL-12.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Takenaka, H.et al.: "Regulation of T cell-dependent and -independent IL-12 production by the three Th2-type cytokines IL-10, IL-6, and IL-4." J.Leukoc.Biol.61. 80-87 (1997)
Takenaka, H.等人:“三种 Th2 型细胞因子 IL-10、IL-6 和 IL-4 对 T 细胞依赖性和非依赖性 IL-12 产生的调节。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Maruo,S.et al.: "B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells(APC)during T cell-APC interactions." J.Immunol.158. 120-126 (1997)
Maruo,S.et al.:“在 T 细胞-APC 相互作用期间,B 细胞调节抗原呈递细胞 (APC) 中 CD40 配体诱导的 IL-12 产生。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Maruo,S.: "B cell regulate CD40 ligand-induced IL-12 production in antigen-presenting cells(APC) during T cell/APC interactions." J.Immunol.158. 120-126 (1997)
Maruo,S.:“在 T 细胞/APC 相互作用期间,B 细胞调节抗原呈递细胞 (APC) 中 CD40 配体诱导的 IL-12 产生。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
S.Maruo et al.: "IL-12 produced by antigen-presenting cells induces IL-2-independent proliferation of T helper cell clones." J.Immunol.156. 1748-1755 (1996)
S.Maruo 等人:“抗原呈递细胞产生的 IL-12 诱导 T 辅助细胞克隆的不依赖于 IL-2 的增殖。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
16
    Role of T Cells (Thymus) in H-2-Linked Control of Autoimmune Disease
    • 批准号:
      01570269
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1989
    • 负责人:
      ONO Shiro
    • 依托单位:
    Carachterization of B cell stimulatory factor capable of inducing autoantibody production and its receptor
    国内基金
    海外基金
    S1P诱导LSEC分泌IL-12调控HBV特异性CTL应答的机制及作为HBeAg阴性慢性乙型肝炎急性发作分型标志物的研究
    • 批准号:
      2025JJ50652
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      吴伟民
    • 依托单位:
    Acod 1来源的衣康酸通过表观遗传调控IL-12导致CD8+T细胞功能障碍的
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      刘家洲
    • 依托单位:
    IL-12促进γδTreg细胞分化调控高血压的机制研究
    • 批准号:
      82370431
    • 项目类别:
      面上项目
    • 资助金额:
      49万元
    • 批准年份:
      2023
    • 负责人:
      叶晶
    • 依托单位:
    一种简单的可用于治疗ARS的IL-12递送可注射纳米复合水凝胶系统